Non-white communities had significantly less access to opioid medications commonly prescribed for moderate to severe pain than white communities over the decade beginning in 2011, according to a study by Weill Cornell Medicine researchers.
A study out of Weill Cornell Medicine and Oregon Health & Science University provides critical insight for the development of a vaccine that can more effectively block the spread of cytomegalovirus across the placenta to babies before they're born.
A Cornell Tech-led research group is in the early stages of developing a portable, inexpensive device that uses radio frequency signals and machine learning to measure lead contamination levels in soil.
Professor Wendy Ju has been awarded a place in the Class of 2025 of the prestigious Association for Computing Machinery Special Interest Group on Computer-Human Interaction Academy.
Dr. Jim Castellanos, Ph.D. ’18, M.D. ’20, an instructor in anesthesiology at Weill Cornell Medicine, has been selected as a 2024 Hanna H. Gray Fellow by the Howard Hughes Medical Institute.
Weill Cornell Medicine has received a five-year, $2.3 million grant from the Centers for Disease Control and Prevention to improve equitable access to care, quality of life and survival outcomes for young people with all stages of breast cancer.
A total of 450 expected graduates in the Class of 2025 received their degrees from Weill Cornell Medicine during the institution’s annual Commencement ceremony, held May 15 at Carnegie Hall.
A newer hepatitis B vaccine was superior to an older type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, according to a study led by a Weill Cornell Medicine investigator.